EUVIMEDEUVIMED entdecken
Crossref

Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway

Wanli Xue, Rui Sun, Zheng Hao, Zhenzhen Xing, Hongjie Cheng, Lei Shao

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Wanli Xue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Stomach Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tetrandrine (Tet), a traditional Chinese herbal medicine extract, exhibits anti‐cancer effect on many types of cancer. Nonetheless, the action mechanism of Tet in gastric cancer (GC) is still largely unclear. In the current study, proliferation, invasion, and migration of the BGC‐823 and MKN‐45 cells were effectively suppressed by Tet treatment in a dose‐dependent manner. Moreover, Tet suppressed expression of the proliferation‐associated protein PCNA, the interstitial cell phenotype N‐cadherin, and the extracellular matrix‐associated MMP‐2 and MMP‐9 in BGC‐823 and MKN‐45 cells in a dose‐dependent manner. PI3K/AKT/mTOR, a cancer promoting signaling, was inactivated by Tet in a dose‐dependent manner in BGC‐823 and MKN‐45 cells. Furthermore, our results demonstrated that the inhibition of Tet to PCNA, N‐cadherin, MMP‐2, and MMP‐9 expression was partly rescuedby AKT inhibitor or mTOR inhibitor. In animal experiments, tumor growth was inhibited by Tet administration in a dose‐dependent manner. In conclusion, the current data indicated that Tet had a critical effect on inhibiting BGC‐823 and MKN‐45 cells proliferation, migration, invasion, and tumor growth via regulating PI3K/AKT/mTOR signaling pathway, suggesting that Tet might be a potential treatment for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktStomach NeoplasmsAnimalsMatrix Metalloproteinase 9Matrix Metalloproteinase 2Phosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenCell MovementSignal TransductionTOR Serine-Threonine KinasesCell ProliferationCell Line, TumorBenzylisoquinolines

Stichwörter der Autor:innen

anti-tumorgastric cancernatural producttetrandrinetraditional Chinese medicine

Substanzen

Proto-Oncogene Proteins c-aktMatrix Metalloproteinase 9Matrix Metalloproteinase 2Phosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenTOR Serine-Threonine KinasestetrandrineBenzylisoquinolines

Autor:innen und Institutionen

  • Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China.
  • Department of Endocrinology, The People's Hospital of Jiaozuo City, Jiaozuo, China.

Zitieren

APA

Xue, W., Sun, R., Hao, Z., Xing, Z., Cheng, H., & Shao, L. (2023). Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14202

Vancouver

Xue W, Sun R, Hao Z, Xing Z, Cheng H, Shao L. Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14202

BibTeX
@article{Xue2023,
  author = {Xue, Wanli and Sun, Rui and Hao, Zheng and Xing, Zhenzhen and Cheng, Hongjie and Shao, Lei},
  title = {Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14202}
}
Kostenlos starten →